Blog

Clinical Evaluation of Orphan Medical Devices
||,
What is a Orphan Medical Device? Orphan devices (ODs) are medical devices or their accessories,...
continue reading
June Regulatory Updates
||,
Biocides: Concerns Over Surge in Animal Testing Due to Endocrine Disruptors Deadline Deadline Imposes Increased...
continue reading
Milestones of Food Supplements’ Marketing Procedure: EU and US in Comparison
||,
The global food supplement market has been experiencing steady growth for the last few years....
continue reading
MoCRA: How Chemsafe USA Can Secure Your Cosmetic Compliance
||,
Modernization of Cosmetics Regulation Act (MoCRA) The publication of the Modernization of Cosmetic Regulation Act...
continue reading
May Regulatory Updates
||,
Biocides: European Commission Extends Biocides Review Program Program Extension: The European Commission has officially extended...
continue reading
The Labeling of Plant Protection Products
||,
What is the purpose of a product label? The label must offer consumers information about...
continue reading
New ERA Guideline released on March 2024 by EMA. What changes in the Environmental Risk Assessment of medicines (ERA)?
||,
What is the environmental impact assessment of active pharmaceutical ingredients? Environmental impact assessment of active...
continue reading
Microorganisms in Food Production: a New Trend
||,
Consumer safety in first place Throughout history, microorganisms have played a pivotal role in food...
continue reading
April Regulatory Updates
||,
Biocides: IUCLID Version 8.0.1 Launches with Comprehensive Updates New Format Enhancements: IUCLID version 8.0.1 is...
continue reading
New drug directive approved on April 11, 2024 by the European Parliament. What changes in the environmental risk assessment of medicines (ERA)?
||,
What does it mean to perform an environmental impact assessment of active pharmaceutical ingredients? Environmental...
continue reading